Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPets at home Regulatory News (PETS)

Share Price Information for Pets at home (PETS)

Share Price is delayed by 15 minutes
Get Live Data
183.30    1.10 (0.60%)
Bid:
182.90
Ask:
183.40
Spread: 0.50 (0.273%)
Market Cap: £810.70m
PETS Live PriceLast checked at - London Stock Exchange

Intraday Pets at home Share Chart

FY25 pre-close statement

31 Mar 2025 07:00

RNS Number : 7900C
Pets At Home Group Plc
31 March 2025
 

 

 

 

 

FOR IMMEDIATE RELEASE, 31 MARCH 2025

Pets at Home Group Plc: FY25 pre-close statement

Pets at Home Group plc, the UK's leading pet care business, today provides a pre-close update in respect to the 52-week period to 27 March 2025.

For FY25:

Group underlying profit before tax (PBT) for FY25 is expected to be £133m, in line with previous guidance.

Q4 trends have been broadly as we planned across Retail and Vets, against a challenging and volatile UK consumer backdrop.

We finish FY25 with record numbers of Pets Club members, higher customer satisfaction and having grown our clinical talent with more vets and more vet nurses.

We have successfully completed the transition of online sales to our Stafford distribution centre, meaning we begin FY26 with a single DC, having completed our network optimisation.

Our new digital platform is also now functioning well, with particularly strong growth in subscriptions.

The completion of our network optimisation and new digital platform mean we have now fully completed our two major strategic programs, setting our retail business up to return to sales growth and market outperformance in FY26.

We expect to finish FY25 in a net cash position, after having return c£85m to investors during the year.

 

As we look to FY26:

We expect the current market conditions and subdued consumer backdrop to continue into the new financial year. 

In our Vet Group, which now represents more than half of our Group underlying PBT:

-

We expect further progress in underlying PBT albeit against the comparative of the exceptional levels of growth delivered in FY24 and FY25.

-

Going forward we are accelerating the rollout of new practices, and will deliver at least 10 in FY26, together with a further 15 extensions.

-

We now expect the provisional findings of the CMA to be released over Summer 2025, rather than previous expectations of May 2025.

We will invest c£3m in a new, capital-light insurance proposition which will leverage our best-in-class consumer data, large customer base and leading brand.

In Retail:

-

Given the uncertain economic backdrop for both demand and inflation, our plan for FY26 assumes subdued UK pet retail market growth continues. Against this, we expect to outperform the market as our investments in digital bear fruit.

-

In this uncertain environment we will focus on what we can control: putting consumers at the heart of our business, being committed to remaining competitive and keeping tight control of our cost base.

-

We are facing cost increases including the externally imposed headwinds of NLW/NICs (c£18m impact) and new packaging regulations (£2m), the rebuild of variable pay (c£10m) and we are investing a further £3m in marketing costs to drive sales.

-

We plan to make significant savings through material cost reduction and productivity initiatives to deliver no more than a 5% increase in operating costs in FY26.

-

The extent to which we can further mitigate cost inflation will depend on the rate of sales growth we are able to deliver, which is dependent on how consumer demand evolves and how inflation comes through.

-

Overall, taking into account our current view of demand and costs we expect Retail underlying PBT to decline year on year.

Taking all this into account, this would lead to a FY26 Group underlying PBT outcome down year on year, within a range of £115-125m.

Having gone through a period of significant change in the business over the past 2 years, we are now through this period of disruption and elevated investment. FY26 will see capex return to normalised levels of less than £50m and we do not expect any non-underlying costs.

We remain highly cash generative and will continue to deploy capital in line with our established framework, remaining committed to our ordinary dividend.

 

Our next scheduled update will be our FY25 preliminary results announcement on 28 May 2025.

 

Investor Relations Enquiries

Pets at Home Group Plc:

Andrew Porteous, Director of Investor Relations

+44 (0) 7740 361 849

Aaron Wood, Head of Investor Relations

+44 (0) 7702 083 154

 

Media Enquiries

Pets at Home Group Plc

Natalie Cullington, Head of Communications

+44 (0) 7974 594 701

Citigate Dewe Rogerson:

Angharad Couch

+44 (0) 7507 643 004

 

About Pets at Home

Pets at Home Group Plc is the UK's leading pet care business, providing pets and their owners with the very best advice, products

and care. Pet products are available online or from over 450 pet care centres, many of which also have vet practices and grooming

salons. The Group also operates a leading small animal veterinary business, with over 440 veterinary general practices located both

in our pet care centres and in standalone locations. For more information visit: https://www.petsathomeplc.com/

Disclaimer

This trading statement does not constitute an invitation to underwrite, subscribe for, or otherwise acquire or dispose of any Pets at Home Group Plc shares or other securities nor should it form the basis of or be relied on in connection with any contract or commitment whatsoever. It does not constitute a recommendation regarding any securities. Past performance, including the price at which the Company's securities have been bought or sold in the past, is no guide to future performance and persons needing advice should consult an independent financial adviser. Certain statements in this trading statement constitute forward-looking statements. Any statement in this document that is not a statement of historical fact including, without limitation, those regarding the Company's future plans and expectations, operations, financial performance, financial condition and business is a forward-looking statement. Such forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially. These risks and uncertainties include, among other factors, changing economic, financial, business or other market conditions. These and other factors could adversely affect the outcome and financial effects of the plans and events described in this statement. As a result, you are cautioned not to place reliance on such forward-looking statements. Nothing in this statement should be construed as a profit forecast.

 

This announcement contains information that is inside information for the purposes of Article 7 of the UK version of Regulation (EU) No. 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended (the Market Abuse Regulation ("MAR")). Upon the publication of this announcement, such information will no longer constitute inside information. Andrew Porteous, the Company's Director of Investor Relations, is the person responsible for making the notification for the purposes of Article 17 of MAR.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTJPMLTMTTTBJA
Date   Source Headline
11th Dec 20193:41 pmRNSHolding(s) in Company
11th Dec 20197:01 amRNSHolding(s) in Company
6th Dec 20193:28 pmRNSHolding(s) in Company
28th Nov 20191:15 pmRNSHolding(s) in Company
26th Nov 20197:00 amRNSHalf-year Report
25th Nov 20193:53 pmRNSHolding(s) in Company
22nd Nov 20199:29 amRNSHolding(s) in Company
11th Nov 20199:23 amRNSHolding(s) in Company
8th Nov 20194:30 pmRNSHolding(s) in Company
7th Nov 20199:43 amRNSHolding(s) in Company
31st Oct 20198:57 amRNSHolding(s) in Company
29th Oct 20195:34 pmRNSHolding(s) in Company
28th Oct 20195:23 pmRNSHolding(s) in Company
24th Oct 20194:57 pmRNSHolding(s) in Company
24th Oct 20197:00 amRNSHolding(s) in Company
20th Sep 20192:15 pmRNSHolding(s) in Company
13th Sep 201912:41 pmRNSHolding(s) in Company
12th Sep 20197:00 amRNSHolding(s) in Company
2nd Aug 20197:00 amRNSTrading Statement
11th Jul 20191:52 pmRNSResult of AGM
14th Jun 20193:20 pmRNSHolding(s) in Company
11th Jun 20197:10 amRNSHolding(s) in Company
11th Jun 20197:00 amRNSAnnual Report & Accounts and AGM Notice
6th Jun 201910:48 amRNSDirector/PDMR Shareholding
6th Jun 201910:47 amRNSDirector/PDMR Shareholding
6th Jun 201910:45 amRNSDirector/PDMR Shareholding
4th Jun 20195:56 pmRNSChange in Director's details
4th Jun 20192:24 pmRNSDirector/PDMR Shareholding
4th Jun 20192:22 pmRNSDirector/PDMR Shareholding
4th Jun 20192:21 pmRNSDirector/PDMR Shareholding
29th May 20191:39 pmRNSHolding(s) in Company
22nd May 20197:00 amRNSFull Year Results
1st May 20194:43 pmRNSHolding(s) in Company
16th Apr 20191:06 pmRNSHolding(s) in Company
15th Apr 20194:55 pmRNSHolding(s) in Company
12th Apr 20193:26 pmRNSHolding(s) in Company
12th Apr 20197:00 amRNSResult of Placing
11th Apr 20194:52 pmRNSProposed Placing
8th Apr 20197:00 amRNSHolding(s) in Company
1st Apr 20194:47 pmRNSHolding(s) in Company
29th Mar 20194:05 pmRNSHolding(s) in Company
22nd Mar 20192:57 pmRNSHolding(s) in Company
20th Mar 20193:29 pmRNSHolding(s) in Company
13th Mar 20197:00 amRNSNotification of Major Holdings
12th Mar 20197:00 amRNSDisclosure to Issuer
7th Feb 20195:15 pmRNSDirector/PDMR Shareholding
22nd Jan 201912:52 pmRNSHolding(s) in Company
22nd Jan 20197:00 amRNSTrading Statement
17th Jan 20197:00 amRNSHolding(s) in Company
10th Jan 20195:16 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.